Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 45 articles: HTML format Text format

Single Articles

June 2019
1. ZHAO B, Tsai C, Hunt KK, Blair SL, et al
   Adherence to surgical and oncologic standards improves survival in breast cancer patients.
   J Surg Oncol. 2019 Jun 6. doi: 10.1002/jso.25506.
   PubMed     Text format     Abstract available
   
   
   
2. CORSI F, Bossi D, Combi F, Papadopoulou O, et al
   Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population: A propensity score-matched study.
   J Surg Oncol. 2019;119:916-924.
   PubMed     Text format     Abstract available
   
   
   
3. CHAUDHRY A, Oliver JD, Vyas KS, Alsubaie SA, et al
   Outcomes analysis of Goldilocks mastectomy and breast reconstruction: A single institution experience of 96 cases.
   J Surg Oncol. 2019;119:1047-1052.
   PubMed     Text format     Abstract available
   
   
   May 2019
4. BRUENDERMAN EH, Bhutiani N, Mercer MK, McMasters KM, et al
   Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.
   J Surg Oncol. 2019;119:694-699.
   PubMed     Text format     Abstract available
   
   
   March 2019
5. ZHONG W, Tan L, Jiang WG, Chen K, et al
   Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis.
   J Surg Oncol. 2019 Mar 20. doi: 10.1002/jso.25457.
   PubMed     Text format     Abstract available
   
   
   
6. VIEIRA RAC, Boni RADS, Silva VD
   Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall based on a systematic review of thoracoabdominal flaps.
   J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25436.
   PubMed     Text format    
   
   
   
7. BURATTINI ACB, Horacio GS, Beloti TR
   Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps.
   J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25439.
   PubMed     Text format    
   
   
   
8. TAN MG, Isaranuwatchai W, DeLyzer T, Butler K, et al
   A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical breast reconstruction.
   J Surg Oncol. 2019;119:388-396.
   PubMed     Text format     Abstract available
   
   
   
9. BANKS A, Coronado G, Zimmerman R, Iyengar G, et al
   Breast conserving surgery with targeted intraoperative radiotherapy for the management of ductal carcinoma in situ.
   J Surg Oncol. 2019;119:409-420.
   PubMed     Text format     Abstract available
   
   
   February 2019
10. PARK KU, Kyrish K, Terrell J, Yi M, et al
    Surgeon perception versus reality: Opioid use after breast cancer surgery.
    J Surg Oncol. 2019 Feb 8. doi: 10.1002/jso.25395.
    PubMed     Text format     Abstract available
    
    
    January 2019
11. DASGUPTA H, Islam S, Alam N, Roy A, et al
    Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
    J Surg Oncol. 2019;119:88-100.
    PubMed     Text format     Abstract available
    
    
    December 2018
12. HELLINGMAN D, de Wit-van der Veen BJ, Wan OY, van der Ploeg IM, et al
    Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25339.
    PubMed     Text format     Abstract available
    
    
    
13. LAWS A, Brar MS, Bouchard-Fortier A, Leong B, et al
    Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
    J Surg Oncol. 2018;118:1205-1211.
    PubMed     Text format     Abstract available
    
    
    
14. JIN L, Wu X, Zha L, Feng Y, et al
    Adjacent skin rotation flap for large defect in primary breast tumor.
    J Surg Oncol. 2018;118:1199-1204.
    PubMed     Text format     Abstract available
    
    
    November 2018
15. BERGER ER, Bilimoria KY, Kinnier CV, Minami CA, et al
    Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25294.
    PubMed     Text format     Abstract available
    
    
    
16. PANCHAL H, Pilewskie ML, Sheckter CC, Albornoz CR, et al
    National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25315.
    PubMed     Text format     Abstract available
    
    
    
17. YU TJ, Liu YY, Hu X, Di GH, et al
    No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    J Surg Oncol. 2018;118:928-935.
    PubMed     Text format     Abstract available
    
    
    
18. OLASEHINDE O, Alatise O, Arowolo O, Adisa A, et al
    Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.
    J Surg Oncol. 2018;118:861-866.
    PubMed     Text format     Abstract available
    
    
    
19. XU F, Sun H, Zhang C, Jiang H, et al
    Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 cases.
    J Surg Oncol. 2018;118:953-958.
    PubMed     Text format     Abstract available
    
    
    
20. MAY M, Chin C, Hirji S, Horowitz D, et al
    Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy.
    J Surg Oncol. 2018;118:959-965.
    PubMed     Text format     Abstract available
    
    
    October 2018
21. JOHNSON AR, Singhal D
    Immediate lymphatic reconstruction.
    J Surg Oncol. 2018;118:750-757.
    PubMed     Text format     Abstract available
    
    
    September 2018
22. BEAR HD, Wan W, Robidoux A, Rubin P, et al
    Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
    J Surg Oncol. 2018;118:722.
    PubMed     Text format    
    
    
    
23. HO OA, Lin YL, Pappalardo M, Cheng MH, et al
    Nipple-sparing mastectomy and breast reconstruction with a deep inferior epigastric perforator flap using thoracodorsal recipient vessels and a low lateral incision.
    J Surg Oncol. 2018;118:621-629.
    PubMed     Text format     Abstract available
    
    
    August 2018
24. OHASHI R, Namimatsu S, Sakatani T, Naito Z, et al
    Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25152.
    PubMed     Text format     Abstract available
    
    
    July 2018
25. SUSNIK B, Schneider L, Swenson KK, Krueger J, et al
    Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
    J Surg Oncol. 2018;118:221-227.
    PubMed     Text format     Abstract available
    
    
    
26. YOON-FLANNERY K, DeStefano LM, De La Cruz LM, Fisher CS, et al
    Quality of life and sexual well-being after nipple sparing mastectomy: A matched comparison of patients using the breast Q.
    J Surg Oncol. 2018;118:238-242.
    PubMed     Text format     Abstract available
    
    
    
27. SMITH JR, Jaffe J, Pruitt J, Yao K, et al
    The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
    J Surg Oncol. 2018;118:212-220.
    PubMed     Text format     Abstract available
    
    
    June 2018
28. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
    High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
    PubMed     Text format     Abstract available
    
    
    
29. ROSTAS JW, Bhutiani N, Crigger M, Crawford SMW, et al
    Calculation of breast volumes from mammogram: Comparison of four separate equations relative to mastectomy specimen volumes.
    J Surg Oncol. 2018;117:1848-1853.
    PubMed     Text format     Abstract available
    
    
    May 2018
30. SHEN S, Xu Q, Zhou Y, Mao F, et al
    Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
    PubMed     Text format     Abstract available
    
    
    April 2018
31. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
    Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    J Surg Oncol. 2018;117:1001-1008.
    PubMed     Text format     Abstract available
    
    
    March 2018
32. ALTUNDAG K
    Breast cancer subtypes and local recurrence rate after surgery for bone metastasis to the extremities.
    J Surg Oncol. 2018 Mar 30. doi: 10.1002/jso.24987.
    PubMed     Text format    
    
    
    
33. FOSTER D, Choy N, Porter C, Ahmed S, et al
    Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    J Surg Oncol. 2018;117:336-340.
    PubMed     Text format     Abstract available
    
    
    
34. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    PubMed     Text format     Abstract available
    
    
    February 2018
35. PERCY DB, Pao JS, McKevitt E, Dingee C, et al
    Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25010.
    PubMed     Text format     Abstract available
    
    
    December 2017
36. GERVAIS MK, Burtenshaw SM, Maxwell J, Dickson BC, et al
    Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.
    J Surg Oncol. 2017;116:1056-1061.
    PubMed     Text format     Abstract available
    
    
    
37. GIANNINI V, Bianchi V, Carabalona S, Mazzetti S, et al
    MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.
    J Surg Oncol. 2017;116:1069-1078.
    PubMed     Text format     Abstract available
    
    
    
38. ALVARADO M, Lucci A, Manders J
    Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.
    J Surg Oncol. 2017;116:1016-1020.
    PubMed     Text format     Abstract available
    
    
    
39. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    PubMed     Text format     Abstract available
    
    
    
40. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    PubMed     Text format     Abstract available
    
    
    November 2017
41. TATARA T, Mukohara T, Shimono Y, Yamasaki T, et al
    Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24937.
    PubMed     Text format     Abstract available
    
    
    
42. ONEGA T, Weiss JE, Goodrich ME, Zhu W, et al
    Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24796.
    PubMed     Text format     Abstract available
    
    
    October 2017
43. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    PubMed     Text format     Abstract available
    
    
    
44. ALTUNDAG K
    Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    J Surg Oncol. 2017 Oct 2. doi: 10.1002/jso.24839.
    PubMed     Text format    
    
    
    September 2017
45. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: